Implementing anticoagulation management by pharmacists in the inpatient setting

被引:27
作者
Dager, William E.
Gulseth, Michael P.
机构
[1] Univ Calif Davis, Med Ctr, Dept Pharmaceut Serv, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA
[4] Univ Minnesota, Coll Pharm, Dept Pharm, Duluth, MN 55812 USA
[5] St Marys Hosp, Duluth, MN USA
关键词
administration; anticoagulants; drugs; health-benefit programs; interventions; patient information; pharmaceutical services; pharmacists; hospital; pharmacy; institutional; protocols; thromboembolism; toxicity; warfarin;
D O I
10.2146/ajhp060133
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. This article identifies approaches for implementing an inpatient anticoagulation program involving pharmacists; two successful inpatient anticoagulation programs previously reported in the literature are described with a discussion of steps to consider in developing or expanding such a service. Summary. Two institutions implemented pharmacist-managed anticoagulation services. One institution identified an undesirable incidence of medication-related adverse events occurring in hospitalized patients receiving anticoagulants. Pharmacists were asked to assist. Pharmacist activities included the selection of anticoagulants, patient education, verification of insurance coverage of the patient's anticoagulant, and coordination of follow-up. Physicians were available to assist. At the other institution, the department of pharmacy was asked by the orthopedic surgeons to manage warfarin for the prophylaxis against venous thromboembolism. The pharmacy department worked with the medical staff to gain approval of all policies, guidelines, and protocols to establish an anticoagulation service. Because of the success of the program, the pharmacy department expanded the service beyond warfarin. The steps to establishment of an anticoagulation service are described. The challenges facing such programs are discussed, including the potential anticoagulants in development that will create ongoing challenges in deciding which anticoagulation approach to use and in identifying patients for whom the newer agents may or may not be best suited. Conclusion. Requirements for establishing a successful inpatient anticoagulation management program included defining the pharmacist's role in identifying patient needs, gaining support from other health care professionals, designing a program that addresses the needs of the patients, and managing unanticipated issues.
引用
收藏
页码:1071 / 1079
页数:9
相关论文
共 39 条
[1]   Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty [J].
Anderson, DR ;
Wilson, SJA ;
Blundell, J ;
Petrie, D ;
Leighton, R ;
Stanish, W ;
Alexander, D ;
Robinson, KS ;
Burton, E ;
Gross, M .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (11) :1992-1997
[2]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[3]   Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview [J].
Bernardi, E ;
Piccioli, A ;
Oliboni, G ;
Zuin, R ;
Girolami, A ;
Prandoni, P .
THROMBOSIS AND HAEMOSTASIS, 2000, 84 (01) :22-26
[4]   Pharmacist involvement with warfarin dosing for inpatients [J].
Boddy, C .
PHARMACY WORLD & SCIENCE, 2001, 23 (01) :31-35
[5]   Pharmacist-provided anticoagulation management in United States hospitals: Death rates, length of stay, medicare charges, bleeding complications, and transfusions [J].
Bond, CA ;
Raehl, CL .
PHARMACOTHERAPY, 2004, 24 (08) :953-963
[6]   Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: The LEAP program [J].
Bridges, GG ;
Lee, MD ;
Jenkins, JK ;
Stephens, MA ;
Croce, MA ;
Fabian, TC .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (02) :232-235
[7]   A randomized trial comparing 5-mg and 10-mg warfarin loading doses [J].
Crowther, MA ;
Ginsberg, JB ;
Kearon, C ;
Harrison, L ;
Johnson, J ;
Massicotte, P ;
Hirsh, J .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) :46-48
[8]  
DAGER W, 2005, J THROMB HAEMOST S1, V3, pP1955
[9]   Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis [J].
Dager, WE ;
King, JH ;
Branch, JM ;
Chow, SL ;
Ferrer, RE ;
Pak, S ;
Togioka, PY ;
White, RH .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) :1182-1187
[10]   Optimization of inpatient warfarin therapy: Impact of daily consultation by a pharmacist-managed anticoagulation service [J].
Dager, WE ;
Branch, JM ;
King, JH ;
White, RH ;
Quan, RS ;
Musallam, NA ;
Albertson, TE .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) :567-572